BevacizumabAllergy and hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33702-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：72 / 72

相关论文

共 50 条

[31] LorlatinibPulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2018, 1731 (1) : 169 - 169
[32] DasatinibPulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2019, 1770 (1) : 140 - 140
[33] MitomycinFatal pulmonary hypertension: 2 case reports
Reactions Weekly, 2002, 915 (1) : 10 - 10
[34] DasatinibPulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2015, 1580 (1) : 136 - 136
[35] OctreotideAllergic reaction and hypertension in children: 2 case reports
Reactions Weekly, 2011, 1360 (1) : 28 - 28
[36] Bupivacaine/lidocaine/epinephrineTransient hypertension: 2 case reports
Reactions Weekly, 2013, 1444 (1) : 13 - 13
[37] Paclitaxel/ramucirumabInterstitial pneumonia and hypertension: 2 case reports
Reactions Weekly, 2019, 1740 (1) : 258 - 258
[38] DroxidopaAbdominal pain, nausea and hypertension: 2 case reports
Reactions Weekly, 2019, 1748 (1) : 193 - 193
[39] OxytocinExacerbation of pulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2019, 1735 (1) : 206 - 206
[40] BevacizumabOcular hypertension, and rubeotic glaucoma: 2 case reports
Reactions Weekly, 2015, 1575 (1) : 41 - 41

← 1 2 3 4 5 →